South & Central America Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, and Others); Ro

South & Central America Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, and Others); Route of Administration (Oral, and Parenteral); Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, and Others); and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country

The South and Central America gastrointestinal drugs market is expected to reach US$ 5,632.72 million by 2027 from US$ 4,160.28 million in 2019; it is expected to grow at a CAGR of 4.0% from 2020 to 2027. Rising prevalence of gastrointestinal (GI) diseases and increase in development of biologics are expected to boost the growth of the market. However, factors such as low awareness associated with gastrointestinal disorders in low-income economies are likely to restrain the growth of the market. Additionally, increasing investment in research activities coupled with growing pipeline of GI candidates and emergence of biosimilars are likely to fuel the growth of the gastrointestinal drugs market during the forecast period.

Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small and large intestine, and rectum. The disorders include constipation, irritable bowel, ulcerative colitis (UC), and peptic ulcer diseases. These disorders are characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. These disorders constitute a large proportion of outpatients and frequent hospital visits. A wide range of GI drugs is commercially available in the market for the treatment of various conditions. Additionally, rising investments in the development of biologics and emergence of biosimilars are expected to drive the market during the forecast period.

Gastrointestinal diseases are becoming prevalent. Rapidly progressing research activities in drug development of novel therapeutics are driving the market. Many research institutes are offering funding to accelerate the discovery of novel methods for the treatment of GI disorders, which is offering lucrative opportunities for the market. The major research areas are understanding mechanisms responsible for pancreatic inflammation and pancreatitis genetics and immunobiology of inflammatory bowel disease.

Moreover, the pharmaceutical industry is continually evolving. There is always a need for new, innovative therapeutic approaches in the treatment of various GI indications. The GI candidates-based pipeline is growing for a wide range of therapeutic applications, including Crohn's disease, ulcerative colitis, and inflammatory bowel disease. Many big and small pharmaceutical companies are engaged in the development of several GI biologics drugs. Thus, growing innovative pipeline of GI drugs is, in turn, boosting the drug discovery activities across the industry.

South and Central America is hit by the COVID-19 outbreak, resulting in profound humanitarian, economic, and political consequences. Countries in the region have responded to the situation by closing borders and imposing a host of restrictions to keep people confined at home. Brazilian Health Regulatory Agency has approved RedHill Biopharma Ltd. to conduct clinical trials for its drug for COVID-19.

In 2019, the acid neutralizers segment accounted for the highest share of the market. However, the biologics segment is expected to be the fastest-growing segment during the forecast period. The biologics segment is anticipated to register the highest CAGR during the forecast period. The growth of the segment is attributed to growing product development and increasing product launches in the market.

A few of the major secondary sources associated with the South and Central America gastrointestinal drugs market report are World Health Organization, InterAmerican Heart Foundation, Brazilian Health Regulatory Agency, and International Foundation for Gastrointestinal Disorders.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America gastrointestinal drugs market.

Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America gastrointestinal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.


1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Gastrointestinal Drugs Market – By Drug Class
1.3.2 South and Central America Gastrointestinal Drugs Market – By Route of Administration
1.3.3 South and Central America Gastrointestinal Drugs Market – By Application
1.3.4 South and Central America Gastrointestinal drugs Market – By Distribution Channel
1.3.5 South and Central America Gastrointestinal drugs Market – By Country
2. South and Central America Gastrointestinal Drugs Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South and Central America Gastrointestinal Drugs Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Gastrointestinal Drugs Market - South and Central America PEST Analysis
4.3 Expert Opinion
5. South and Central America Gastrointestinal Drugs Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal (GI) Diseases
5.1.2 Increase in Development of Biologics
5.2 Market Restraints
5.2.1 Side Effects Associated with The Drugs
5.3 Market Opportunities
5.3.1 Increasing Investment in Research Activities and Growing Pipeline of GI Candidates
5.4 Future Trends
5.4.1 Emergence of Biosimilars
5.5 Impact Analysis
6. Gastrointestinal Drugs Market – South and Central America Analysis
6.1 South and Central America Gastrointestinal Drugs Market Revenue Forecasts and Analysis
7. South and Central America Gastrointestinal Drugs Market Analysis And Forecasts To 2027 – By Drug Class
7.1 Overview
7.2 South and Central America Gastrointestinal Drugs Market, By Drug Class 2019 & 2027 (%)
7.2.1 South and Central America Gastrointestinal drugs Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)
7.3 Acid Neutralizers
7.3.1 Overview
7.3.2 South and Central America Acid Neutralizers Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Antidiarrheal and Laxatives
7.4.1 Overview
7.4.2 South and Central America Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Anti-Inflammatory Drugs
7.5.1 Overview
7.5.2 South and Central America Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Antiemetic and Antinauseants
7.6.1 Overview
7.6.2 South and Central America Antiemetic and Antinauseants Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Biologics
7.7.1 Overview
7.7.2 South and Central America Biologics Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Others
7.8.1 Overview
7.8.2 South and Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. South and Central America Gastrointestinal Drugs Market Analysis – By Route of Administration
8.1 Overview
8.2 South and Central America Gastrointestinal Drugs Market, By Route of Administration 2019-2027 (%)
8.2.1 South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)
8.3 Oral
8.3.1 Overview
8.3.2 South and Central America Oral Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Parenteral
8.4.1 Overview
8.4.2 South and Central America Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)
9. South and Central America Gastrointestinal Drugs Market Analysis – By Application
9.1 Overview
9.2 South and Central America Gastrointestinal Drugs Market, By Application 2019-2027 (%)
9.2.1 South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3 Inflammatory Ulcerative Colitis
9.3.1 Overview
9.3.2 South and Central America Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Crohn's Disease
9.4.1 Overview
9.4.2 South and Central America Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Irritable Bowel Syndrome
9.5.1 Overview
9.5.2 South and Central America Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Gastroenteritis
9.6.1 Overview
9.6.2 South and Central America Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Celiac Disease
9.7.1 Overview
9.7.2 South and Central America Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 South and Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. South and Central America Gastrointestinal Drugs Market Analysis – By Distribution Channel
10.1 Overview
10.2 South and Central America Gastrointestinal Drugs Market, By Distribution Channel 2019-2027 (%)
10.2.1 South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.2 South and Central America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Retail Pharmacies
10.4.1 Overview
10.4.2 South and Central America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Online Pharmacies
10.5.1 Overview
10.5.2 South and Central America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
11. Gastrointestinal Drugs Market Revenue and Forecasts To 2027 – Geographical Analysis
11.1 South and Central America Gastrointestinal Drugs Market Revenue and Forecasts To 2027
11.1.1 Overview
11.1.2 South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 South and Central America: Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
11.1.4 South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
11.1.5 South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)
11.1.6 South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.7 South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
11.1.8 Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 Brazil: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)
11.1.8.3 Brazil: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
11.1.8.4 Brazil: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)
11.1.8.5 Brazil: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.9 Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Argentina: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)
11.1.9.3 Argentina: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
11.1.9.4 Argentina: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)
11.1.9.5 Argentina: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.10 Rest of South and Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Rest of South and Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)
11.1.10.3 Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
11.1.10.4 Rest of South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)
11.1.10.5 Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
12. Impact of COVID-19 Pandemic on South and Central America Gastrointestinal Drugs Market
12.1 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Company Profiles
13.1 Takeda Pharmaceutical Company Limited
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Celltrion Healthcare Co.,Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 AstraZeneca
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 Glossary of Terms
List of Tables
Table 1. South and Central America Gastrointestinal drugs Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)
Table 2. South and Central America Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)
Table 3. South and Central America Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 4. South and Central America Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 5. South and Central America: Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 6. South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 7. South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 8. South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. Brazil: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)
Table 10. Brazil: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 11. Brazil: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. Brazil: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Argentina: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)
Table 14. Argentina: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 15. Argentina: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 16. Argentina: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)
Table 18. Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 19. Rest of South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 21. Glossary of Terms, Gastrointestinal Drugs Market
list of Figures
Figure 1. Gastrointestinal Drugs Market Segmentation
Figure 2. South and Central America Gastrointestinal Drugs Market Overview
Figure 3. Acid Neutralizers Segment Held Largest Share of Product in Gastrointestinal Drugs Market
Figure 4. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. South and Central America Gastrointestinal Drugs Market - Leading Country Markets (US$ Mn)
Figure 6. Gastrointestinal Drugs Market - South and Central America PEST Analysis
Figure 7. Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint
Figure 8. South and Central America Gastrointestinal Drugs market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. South and Central America Gastrointestinal Drugs Market, By Drug Class 2019 & 2027 (%)
Figure 10. South and Central America Acid Neutralizers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. South and Central America Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. South and Central America Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. South and Central America Antiemetic and Antinauseants Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. South and Central America Biologics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. South and Central America Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. South and Central America Gastrointestinal Drugs Market, by Route of Administration 2019 & 2027 (%)
Figure 17. South and Central America Oral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. South and Central America Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. South and Central America Gastrointestinal Drugs Market, by Application 2019 & 2027 (%)
Figure 20. South and Central America Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. South and Central America Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. South and Central America Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. South and Central America Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. South and Central America Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. South and Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. South and Central America Gastrointestinal Drugs Market, by Distribution Channel 2019 & 2027 (%)
Figure 27. South and Central America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. South and Central America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. South and Central America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. South and Central America: Gastrointestinal Drugs Market , by Key Country – Revenue (2019) (USD Million)
Figure 31. South and Central America: Gastrointestinal Drugs Market, Revenue and Forecast to 2027 (USD Million)
Figure 32. South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
Figure 33. Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Rest of South and Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Rest of the World

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook